BUDESONIDE 160MG+ GLYCOPYRROLATE 7.2 MCG+ FORMOTEROL 5 MG TRIPLE INHALER,FLUTICASONE FUROATE UMECLI
Indian Navy · Mumbai · Pharmaceuticals · open
Key facts
- Published: 28 Jul 2026
- Closing date: 07 Aug 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for supply of 60 units of BUDESONIDE 160MG+ GLYCOPYRROLATE 7.2 MCG+ FORMOTEROL 5 MG TRIPLE INHALER, FLUTICASONE FUROATE UMECLI, with bid validity of 180 days, issued by Indian Navy under Ministry of Defence, Department of Military Affairs.
Eligibility & requirements
- Past performance: 20%
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Relevant contracts, Delivery acceptance certificates, Audited Balance Sheets, CA/Cost Accountant certificates
Commercial terms
- Bid type: Single Packet
- Evaluation: value wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (1)
- BUDESONIDE 160MG+ GLYCOPYRROLATE 7.2 MCG+ FORMOTEROL 5 MG TRIPLE INHALER, FLUTICASONE FUROATE UMECLI — Qty: 60 unit
1 tender document(s) available — sign up to download.